Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats

Cited in:

CrossRef

This article has been cited by:

1. 1
   Karolina Kobus, Justyna Kopycinska, Anna Kozlowska-Wiechowska, Elzbieta Urasinska, Agnieszka Kempinska-Podhorodecka, Tara L. Haas, Piotr Milkiewicz, Malgorzata Milkiewicz, Angiogenesis within the duodenum of patients with cirrhosis is modulated by mechanosensitive Kruppel-like factor 2 and microRNA-126, Liver International, 2012, 32, 5

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(535K)
   • References
2. 2
   Vicente Arroyo, Javier Fernández, Bases fisiopatológicas del uso de la albúmina humana en la cirrosis hepática, Gastroenterología y Hepatología, 2012, 35, 1, 42

   CrossRef

3. 3
   Hacer Sahin, Erawan Borkham-Kamphorst, Christoph Kuppe, Mirko Moreno Zaldivar, Christoph Grouls, Muhammad Al-samman, Andreas Nellen, Petra Schmitz, Daniel Heinrichs, Marie-Luise Berres, Dennis Doleschel, David Scholten, Ralf Weiskirchen, Marcus J. Moeller, Fabian Kiessling, Christian Trautwein, Hermann E. Wasmuth, Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice, Hepatology, 2012, 55, 5

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(1525K)
   • References
4. 4
   Yasuko Iwakiri, Endothelial dysfunction in the regulation of cirrhosis and portal hypertension, Liver International, 2012, 32, 2

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(720K)
   • References
5. 5
   Hui-Chun Huang, Omar Haq, Teruo Utsumi, Supatsri Sethasine, Juan G. Abraldes, Roberto J. Groszmann, Yasuko Iwakiri, Intestinal and plasma VEGF levels in cirrhosis: the role of portal pressure, Journal of Cellular and Molecular Medicine, 2012, 16, 5

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(396K)
   • References
6. 6
   Hisashi Hidaka, Takahide Nakazawa, Toru Kaneko, Tsutomu Minamino, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Masaaki Watanabe, Akitaka Shibuya, Wasaburo Koizumi, Portal hemodynamic effects of sorafenib in patients with advanced hepatocellular carcinoma: a prospective cohort study, Journal of Gastroenterology, 2012,

   CrossRef

7. 7
   Aina Rodríguez-Vilarrupla, Bàrbara Laviña, Héctor García-Calderó, Lucia Russo, Eugenio Rosado, Núria Roglans, Jaume Bosch, Joan Carles García-Pagán, PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats, Journal of Hepatology, 2012, 56, 5, 1033

   CrossRef

8. 8
   Chen-Jung Chang, Ming-Chih Hou, Wei-Chih Liao, Fa-Yauh Lee, Han-Chieh Lin, Shou-Dong Lee, Risk factors of early re-bleeding and mortality in patients with ruptured gastric varices and concomitant hepatocellular carcinoma, Journal of Gastroenterology, 2012, 47, 5, 531

   CrossRef

9. 9
   Guanhua Xie, Xiangdong Wang, Lei Wang, Lin Wang, Roscoe D. Atkinson, Gary C. Kanel, William A. Gaarde, Laurie D. DeLeve, Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats, Gastroenterology, 2012, 142, 4, 918

   CrossRef

10. You have free access to this content10
    Giuseppe Cabibbo, Laura Palmeri, Sergio Palmeri, Antonio Craxì, Should cirrhosis change our attitude towards treating non-hepatic cancer?, Liver International, 2012, 32, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(178K)
    • References
11. You have free access to this content11
    M. Pinter, W. Sieghart, T. Reiberger, N. Rohr-Udilova, A. Ferlitsch, M. Peck-Radosavljevic, The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma – a pilot study, Alimentary Pharmacology & Therapeutics, 2012, 35, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(267K)
    • References
12. 12
    Patrick S. Kamath, Vijay H. Shah, Zakim and Boyer's Hepatology, 2012,

    CrossRef

13. 13
    Samuel S. Lee, Soon Koo Baik, Zakim and Boyer's Hepatology, 2012,

    CrossRef

14. 14
    KangAe Lee, Celeste M. Nelson, International Review of Cell and Molecular Biology Volume 294, 2012,

    CrossRef

15. 15
    Rajeshwar P Mookerjee, Acute-on-chronic liver failure: the liver and portal haemodynamics, Current Opinion in Critical Care, 2011, 17, 2, 170

    CrossRef

16. 16
    Gang Il Cheon, Jin Oh Kim, Sung Wook Hong, Seong Ran Jeon, Tae Hee Lee, Hyun Gun Kim, Won Young Cho, Wan Jung Kim, Min Jeong Kim, Sung Won Jeong, Jae Young Jang, Bong Min Ko, Joo Young Cho, Joon Seong Lee, Capsule Endoscopy for Suspected Small Bowel Bleeding in Patients with Portal Hypertension, Intestinal Research, 2011, 9, 2, 129

    CrossRef

17. 17
    J.-L. Raoul, M. Latournerie, A. Guillygomarc’h, K. Boudjema, O. Audrain, É. Boucher, Carcinoma hepatocelular, EMC - Tratado de Medicina, 2011, 15, 3, 1

    CrossRef

18. 18
    JX Du, Chinese herbal medicine Xiayuxue Decoction inhibits liver angiogenesis in rats with carbon tetrachloride-induced liver fibrosis, Journal of Chinese Integrative Medicine, 2011, 9, 8, 878

    CrossRef

19. 19
    Dominique Thabut, Chittaranjan Routray, Gwen Lomberk, Uday Shergill, Kevin Glaser, Robert Huebert, Leena Patel, Tetyana Masyuk, Boris Blechacz, Andrew Vercnocke, Erik Ritman, Richard Ehman, Raul Urrutia, Vijay Shah, Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis, Hepatology, 2011, 54, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(3557K)
    • References
20. 20
    Norifumi Kawada, Evolution of hepatic fibrosis research, Hepatology Research, 2011, 41, 3

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(839K)
    • References
21. 21
    Christophe Van Steenkiste, Jordi Ribera, Anja Geerts, Montse Pauta, Sònia Tugues, Christophe Casteleyn, Louis Libbrecht, Kim Olievier, Ben Schroyen, Hendrik Reynaert, Leo A. van Grunsven, Bram Blomme, Stephanie Coulon, Femke Heindryckx, Martine De Vos, Jean Marie Stassen, Stefan Vinckier, Jose Altamirano, Ramón Bataller, Peter Carmeliet, Hans Van Vlierberghe, Isabelle Colle, Manuel Morales-Ruiz, Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice, Hepatology, 2011, 53, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(2148K)
    • References
22. 22
    Marcos Pasarín, Juan G. Abraldes, Aina Rodríguez-Vilarrupla, Vincenzo La Mura, Joan Carles García-Pagán, Jaime Bosch, Insulin resistance and liver microcirculation in a rat model of early NAFLD, Journal of Hepatology, 2011, 55, 5, 1095

    CrossRef

23. 23
    Ulrich Thalheimer, Christos Triantos, John Goulis, Andrew K Burroughs, Management of varices in cirrhosis, Expert Opinion on Pharmacotherapy, 2011, 12, 5, 721

    CrossRef

24. 24
    Christopher Kenneth Opio, Guadalupe Garcia-Tsao, Managing Varices: Drugs, Bands, and Shunts, Gastroenterology Clinics of North America, 2011, 40, 3, 561

    CrossRef

25. 25
    Annalisa Berzigotti, Guadalupe Garcia-Tsao, Jaime Bosch, Norman D. Grace, Andrew K. Burroughs, Rosa Morillas, Angels Escorsell, Juan Carlos Garcia-Pagan, David Patch, Daniel S. Matloff, Roberto J. Groszmann, Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis, Hepatology, 2011, 54, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(262K)
    • References
26. 26
    S. Buob, A.N. Johnston, C.R.L. Webster, Portal Hypertension: Pathophysiology, Diagnosis, and Treatment, Journal of Veterinary Internal Medicine, 2011, 25, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(273K)
    • References
27. 27
    Yue-Lei Chen, Jing Lv, Xiao-Lei Ye, Ming-Yu Sun, Qin Xu, Cheng-Hai Liu, Li-Hua Min, Hui-Ping Li, Ping Liu, Xiaoyan Ding, Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes, Hepatology, 2011, 53, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(707K)
    • References
28. 28
    Augusto Villanueva, Josep M. Llovet, Targeted Therapies for Hepatocellular Carcinoma, Gastroenterology, 2011, 140, 5, 1410

    CrossRef

29. 29
    O. Rosmorduc, Antiangiogenic therapies in portal hypertension: A breakthrough in hepatology, Gastroentérologie Clinique et Biologique, 2010, 34, 8-9, 446

    CrossRef

30. 30
    Moon Young Kim, Soon Koo Baik, Samuel S. Lee, Hemodynamic alterations in cirrhosis and portal hypertension, The Korean Journal of Hepatology, 2010, 16, 4, 347

    CrossRef

31. 31
    Martin Hennenberg, Jonel Trebicka, Zaki Kohistani, Christian Stark, Hans-Dieter Nischalke, Benjamin Krämer, Christian Körner, Sabine Klein, Michaela Granzow, Hans-Peter Fischer, Jörg Heller, Tilman Sauerbruch, Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis, Laboratory Investigation, 2010, 91, 2, 241

    CrossRef

32. 32
    Jaume Bosch, Juan G. Abraldes, Mercedes Fernández, Juan Carlos García-Pagán, Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension, Journal of Hepatology, 2010, 53, 3, 558

    CrossRef

33. 33
    Dominique Thabut, Vijay Shah, Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: New targets for the treatment of portal hypertension?, Journal of Hepatology, 2010, 53, 5, 976

    CrossRef

34. 34
    Guadalupe Garcia-Tsao, Jaime Bosch, Management of Varices and Variceal Hemorrhage in Cirrhosis, New England Journal of Medicine, 2010, 362, 9, 823

    CrossRef

35. 35
    Christophe Van Steenkiste, Steven Staelens, Steven Deleye, Filip De Vos, Stefaan Vandenberghe, Anja Geerts, Christophe Van De Wiele, Martine De Vos, Hans Van Vlierberghe, Isabelle Colle, Measurement of porto-systemic shunting in mice by novel three-dimensional micro-single photon emission computed tomography imaging enabling longitudinal follow-up, Liver International, 2010, 30, 8

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(1663K)
    • References
36. 36
    Yan Wang, Juncha Gao, Di Zhang, Jian Zhang, Junji Ma, Huiqing Jiang, New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis, Journal of Hepatology, 2010, 53, 1, 132

    CrossRef

37. 37
    Guadalupe Garcia-Tsao, Scott Friedman, John Iredale, Massimo Pinzani, Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis, Hepatology, 2010, 51, 4

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(161K)
    • References
38. 38
    Moon Young Kim, Soon Koo Baik, Pathophysiology of Portal Hypertension, What's New?, The Korean Journal of Gastroenterology, 2010, 56, 3, 129

    CrossRef

39. 39
    Emmanuel A. Tsochatzis, Jaime Bosch, Andrew K. Burroughs, Prolonging Survival in Patients With Cirrhosis: Old Drugs With New Indications, Gastroenterology, 2010, 139, 6, 1813

    CrossRef

40. 40
    Marc Mejias, Ester Garcia-Pras, Javier Gallego, Raul Mendez, Jaime Bosch, Mercedes Fernandez, Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension, Journal of Hepatology, 2010, 52, 4, 529

    CrossRef

41. 41
    Jung Il Lee, The effect of sorafenib on hepatic stellate cells: implication of its effect on tumor microenvironment, The Korean Journal of Hepatology, 2010, 16, 4, 418

    CrossRef

42. 42
    S. Erlinger, The Thalidomide renaissance, Gastroentérologie Clinique et Biologique, 2010, 34, 8-9, 426

    CrossRef

43. 43
    Jin Woo Lee, Treatment Update on Portal Hypertension and Complications, The Korean Journal of Gastroenterology, 2010, 56, 3, 144

    CrossRef

44. 44
    Christophe Van Steenkiste, Bram Trachet, Christophe Casteleyn, Denis van Loo, Luc Van Hoorebeke, Patrick Segers, Anja Geerts, Hans Van Vlierberghe, Isabelle Colle, Vascular corrosion casting: analyzing wall shear stress in the portal vein and vascular abnormalities in portal hypertensive and cirrhotic rodents, Laboratory Investigation, 2010, 90, 11, 1558

    CrossRef

45. 45
    Shannon S Glaser, Eugenio Gaudio, Gianfranco Alpini, Vascular factors, angiogenesis and biliary tract disease, Current Opinion in Gastroenterology, 2010, 26, 3, 246

    CrossRef

46. 46
    Vijay H. Shah, Jordi Bruix, Antiangiogenic therapy: Not just for cancer anymore?, Hepatology, 2009, 49, 4

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(166K)
    • References
47. 47
    Moon Young Kim, Soon Koo Baik, Hyperdynamic Circulation in Patients with Liver Cirrhosis and Portal Hypertension, The Korean Journal of Gastroenterology, 2009, 54, 3, 143

    CrossRef

48. 48
    Che-Chang Chan, Portal-systemic Collaterals and Angiogenesis, Journal of the Chinese Medical Association, 2009, 72, 5, 223

    CrossRef

49. 49
    Thomas Reiberger, Bernhard Angermayr, Philipp Schwabl, Natascha Rohr-Udilova, Markus Mitterhauser, Alfred Gangl, Markus Peck-Radosavljevic, Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats, Journal of Hepatology, 2009, 51, 5, 865

    CrossRef

50. 50
    T. Sauerbruch, A.M. Gonzalez-Carmona, S. Nitschmann, Sorafenib bei fortgeschrittenem hepatozellulärem Karzinom, Der Internist, 2009, 50, 11, 1290

    CrossRef

51. 51
    Massimo Pinzani, Antifibrotic Drugs,

    Direct Link:

    • Summary
    • PDF(187K)
    • References
52. 52
    María Gabriela Delgado, Susana Seijo, Jaime Bosch, New Drugs in the Treatment of Portal Hypertension,

    Direct Link:

    • Summary
    • PDF(261K)
    • References